What ChondroFiller costs for a knee injection

ChondroFiller knee injections in the UK are priced on a fixed three-tier model based on the number of boxes of implant used: £3,000 for one box, £5,500 for two boxes, and £8,000 for three. In more severe Grade III/IV cases requiring multiple boxes, costs may reach up to £9,800. These figures come from London Cartilage Clinic at 66 Harley Street, currently the primary UK provider offering ChondroFiller as an outpatient injection.

The per-box structure exists because the ChondroFiller product itself — an acellular collagen scaffold manufactured by Meidrix Biomedicals GmbH in Germany and imported under prescription — is the dominant cost driver. Unlike a flat procedure fee, the total scales directly with the volume of implant needed to fill the cartilage defect. One box treats lesions of approximately 3 cm²; two boxes extend coverage to around 4.5 cm²; three boxes to around 6 cm².

For most patients attending with a focal knee cartilage defect, one box is sufficient, which places the majority of knee cases at the £3,000 entry tier. Larger defects or involvement of more than one compartment may move a patient to the two- or three-box tier, but this is determined at the pre-procedure imaging review rather than assumed in advance.

The pricing schedule is joint-agnostic — the same three tiers apply whether treatment is in the knee, hip, or ankle — so patients researching knee-specific costs can use these figures directly.

What the price includes — and what it doesn't

Each quoted tier — £3,000, £5,500, or £8,000 — is all-inclusive. The fee covers the pre-injection consultation and imaging review, real-time ultrasound guidance during the procedure, the ChondroFiller product itself, the injection, intravenous antibiotic cover, and a six-week clinical follow-up appointment. No separately billed extras are documented in available sources; the figure given is the figure paid.

Some outpatient injection services in the private MSK sector charge imaging, follow-up, or consumables as separate line items, which can make headline prices appear lower than the eventual invoice. Knowing that ChondroFiller pricing bundles these components allows a more accurate comparison when patients have received quotes from other clinics or for other treatments.

The product itself — the acellular collagen scaffold imported from Germany — is described by the clinic as the largest single cost component within each tier, which is why the total scales with the number of boxes rather than carrying a flat procedure premium.

Current sources do not address retreatment pricing; patients who want to understand what a repeat injection would cost should ask the treating clinic directly before committing to the initial course.

How many boxes a knee patient typically needs

Box count — and therefore total cost — cannot be confirmed until a specialist has reviewed the patient's MRI scan. The defect's dimensions, depth, and whether more than one compartment of the knee is involved all factor into that assessment, and none of these can be reliably estimated from symptoms alone.

For a patient ringing ahead to understand likely costs, £3,000 is the appropriate starting reference: most people attending with an isolated focal lesion on a single compartment are found to require one box. Where the MRI shows larger or multi-compartment involvement, the treating clinician will advise on whether two or three boxes are indicated — moving the cost to £5,500 or £8,000 respectively.

The practical implication is that a pre-procedure imaging review, not a telephone enquiry, is the point at which a patient will receive a definitive quote. Patients who already have a recent MRI can bring it to that consultation; those without one will typically need imaging arranged before a treatment decision is made.

NHS funding and private insurance

No NHS pathway currently exists for ChondroFiller, and no NICE appraisal of the treatment has been documented. Patients pursuing this option should expect to self-fund in full; there is no referral route, waiting-list position, or exceptional-funding mechanism that would reduce the cost.

Standard private medical insurance (PMI) policies do not routinely cover ChondroFiller either. However, a small number of UK insurers — Bupa, Aviva, and WPA are the three most often cited — have granted pre-authorisation in individual cases. These approvals are not a given and should not be assumed; each arises from a case-by-case review of the patient's clinical history, policy tier, and specific underwriting terms.

Patients who hold PMI and want to explore coverage can quote CCSD procedure codes W3111 (cartilage regeneration with collagen scaffold) and W8500 to their insurer at the pre-authorisation stage. Using the correct codes gives the clearest description of what is being requested and reduces the risk of miscommunication during the approval process. The insurer guidance outlined here reflects information correct as of October 2025; policy terms change, so confirming current coverage directly with the relevant insurer before any appointment is booked remains important.

Written pre-authorisation must be in place before treatment begins. Verbal assurances, however encouraging, are not a reliable basis for assuming costs will be met. Coverage decisions can vary even between policyholders with the same insurer depending on policy tier, clinical history, and the terms in place at the time of enrolment — no blanket approval across any provider should be assumed.

How ChondroFiller cost compares to other knee injections

Hyaluronic acid (HA) is the injection most patients have already encountered or been offered before reaching a cartilage repair pathway, and its UK cost gives a useful reference point. A single HA injection typically runs to £200–£500; a standard course of three to five injections comes to roughly £600–£2,500 in total.

Placing those figures beside ChondroFiller's £3,000 starting price requires an important qualification: the two treatments are not equivalent clinical options priced at different levels. HA is a viscosupplement — it adds lubrication to an osteoarthritic joint and may ease symptoms for several months, but it does not address a defined cartilage defect. ChondroFiller is an acellular collagen scaffold that works through matrix-induced chondrogenesis, recruiting the patient's own progenitor cells into a focal lesion to support endogenous repair. Its higher cost partly reflects that distinct mechanism and partly the expense of importing a CE-marked Class III medical device from Germany.

Outcome data lend some proportionate context to that price difference. In knee clinical investigations, IKDC scores have consistently improved by approximately 30 points at 12 months following ChondroFiller treatment — a clinically meaningful shift that viscosupplementation does not claim to produce in the same way.

Direct price comparison with other UK ChondroFiller providers is not currently possible, as no independent competitor offers the treatment as an outpatient injection at the time of writing.

Getting assessed for ChondroFiller at Lincolnshire Knee

Patients researching ChondroFiller from outside London do not need to travel to Harley Street. Lincolnshire Knee — part of the MSK Doctors group — offers ChondroFiller as an ultrasound-guided outpatient injection at its Lincolnshire sites in Sleaford (NG34) and Grantham (NG31). No GP referral is required; appointments are available without NHS-style waiting lists.

The right first step is a clinical consultation that includes a review of existing MRI imaging. Box count — and therefore final cost — cannot be confirmed until defect size has been assessed. The pricing set out in this article is therefore a working guide, not a fixed quote. As a practical rule of thumb: a single focal lesion under roughly 3 cm² points to a one-box course and a budget from £3,000; a larger or multi-compartment defect may indicate two or three boxes, placing the likely cost at £5,500 or £8,000 respectively. Arriving at a consultation with a recent MRI and a clear sense of those thresholds puts a patient in the best position to make a grounded decision before any treatment fee is confirmed.

Book an assessment at lincolnshireknee.co.uk.